Esprinet
€7.97Change from previous close: +0.19%Absolute change: +€0.01
Valuation
Data as of October 4, 2026
Valuation multiples
- Market cap
- €393.32M
- Enterprise value
- €728.02M
- P/E (trailing 12 months)
- 18.1
- Forward P/E
- 12.6
- PEG
- 10.7
- Price/book
- 0.96
- Price/sales
- 0.09
- EV/EBITDA
- 12.4
- EV/revenue
- 0.16
Profitability and growth
- Gross margin
- 5.5%
- Operating margin
- 0.8%
- Net margin
- 0.5%
- ROE
- 5.7%
- ROA
- 1.7%
- Revenue growth (year over year)
- 5.7%
- Earnings growth (year over year)
- -38.0%
Financial health
- Total cash
- €112.2M
- Total debt
- €446.9M
- Debt/equity
- 1.19
- Current ratio
- 1.25
- Quick ratio
- 0.66
Dividends
- Annual dividend per share
- €0.35
- Dividend yield
- 4.4%
- Payout ratio
- 79.6%
- Ex-dividend date
- May 4, 2026
Analysts and estimates
- Average price target
- €8.80
- Median price target
- €8.85
- High price target
- €9.00
- Low price target
- €8.50
- Analysts with a price target
- 4
- Forward EPS
- €0.63
- EPS estimate, current year
- €0.59
Shares and trading
- Beta
- 1.23
- Average volume
- 187.1K
- Shares outstanding
- 49.44M
- Float
- 34.18M
- Institutional ownership
- 12.9%
- Insider ownership
- 41.2%